2014
DOI: 10.1016/j.reprotox.2014.10.010
|View full text |Cite
|
Sign up to set email alerts
|

Egr1 is rapidly and transiently induced by estrogen and bisphenol A via activation of nuclear estrogen receptor-dependent ERK1/2 pathway in the uterus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
35
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 46 publications
(36 citation statements)
references
References 38 publications
0
35
0
Order By: Relevance
“…A possibility to explain such sex differences in EGR1 expression could reside in the ovarian hormone estrogen, as the latter can directly up-regulate EGR1 expression. In the mouse mammary gland, for instance, EGR1 is at the center of a gene regulation network triggered by exposure to estrogen (Lu et al, 2008), while its mRNA levels in the mouse uterus are up-regulated following estrogen treatment (Kim et al, 2014). Surprisingly, although an estrogen response element (ERE) has been identified on the Egr1 promoter, the induction of Egr1 transcription by estrogen is mediated by SRF and Elk1 binding to SRE rather than binding of estrogen receptors to their ERE, and is blocked by a MAPK but not PI3K pathway inhibitor in rat cardiomyocytes or MCF-7 human breast cancer cells (Slade and Carter, 2000; Chen et al, 2004), indicating that EGR1 is a downstream target of estrogen’s non-genomic effects.…”
Section: Functions and Regulations Of Egr1mentioning
confidence: 99%
See 1 more Smart Citation
“…A possibility to explain such sex differences in EGR1 expression could reside in the ovarian hormone estrogen, as the latter can directly up-regulate EGR1 expression. In the mouse mammary gland, for instance, EGR1 is at the center of a gene regulation network triggered by exposure to estrogen (Lu et al, 2008), while its mRNA levels in the mouse uterus are up-regulated following estrogen treatment (Kim et al, 2014). Surprisingly, although an estrogen response element (ERE) has been identified on the Egr1 promoter, the induction of Egr1 transcription by estrogen is mediated by SRF and Elk1 binding to SRE rather than binding of estrogen receptors to their ERE, and is blocked by a MAPK but not PI3K pathway inhibitor in rat cardiomyocytes or MCF-7 human breast cancer cells (Slade and Carter, 2000; Chen et al, 2004), indicating that EGR1 is a downstream target of estrogen’s non-genomic effects.…”
Section: Functions and Regulations Of Egr1mentioning
confidence: 99%
“…Surprisingly, although an estrogen response element (ERE) has been identified on the Egr1 promoter, the induction of Egr1 transcription by estrogen is mediated by SRF and Elk1 binding to SRE rather than binding of estrogen receptors to their ERE, and is blocked by a MAPK but not PI3K pathway inhibitor in rat cardiomyocytes or MCF-7 human breast cancer cells (Slade and Carter, 2000; Chen et al, 2004), indicating that EGR1 is a downstream target of estrogen’s non-genomic effects. Interestingly, treatment with progesterone either doesn’t affect Egr1 mRNA (Lu et al, 2008), or dampens the estrogen-induced up-regulation of Egr1 mRNA in the mouse uterus (Kim et al, 2014), which suggests that ovarian hormones can interact to regulate EGR1 expression. These interactions are likely to be specific to neurons, however, as Egr1, among other IEGs, is strongly up-regulated in Schwann cells following progesterone treatment (Mercier et al, 2001).…”
Section: Functions and Regulations Of Egr1mentioning
confidence: 99%
“…In the late phase, E 2 facilitates epithelial cell (EC) proliferation. Recently, we demonstrated that Egr1 is rapidly and transiently induced in both ECs and stromal cells by E 2 via the nuclear estrogen receptor-a (ERa)-ERK1/2 pathway in the uterus (21). Furthermore, Egr1 has been shown to be specifically induced in subluminal stromal cells surrounding the implanted blastocyst (21,22).…”
mentioning
confidence: 99%
“…The EGR1 motif was identified in the promoters of the PRDX5 and TXN genes. EGR1 is a well-known target of the estrogen receptor (ESR1);30 thus, we conjectured that ESR1 might mediate CES signaling, with consequent activation of the AML-1a and Elk1 transcription factors.…”
Section: Resultsmentioning
confidence: 99%